4/A//SEC Filing
Stancic Ana 4/A
Accession 0001140361-10-040782
CIK 0000057055other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 12:45 PM ET
Size
6.5 KB
Accession
0001140361-10-040782
Insider Transaction Report
Form 4/AAmended
KV PHARMACEUTICAL CO /DE/KVA/KVB
Stancic Ana
Director
Transactions
- Award
Option to Purchase
2010-06-24+7,500→ 7,500 totalExercise: $1.14Exp: 2020-06-24→ Class A Common Stock (7,500 underlying)
Holdings
- 0
Class A Common Stock
Footnotes (2)
- [F1]The reporting person inadvertently reported the June 24, 2010 receipt of an option to purchase as a grant of unrestricted common stock on the reporting person's Form 4.
- [F2]The option vests in five euqal installments beginning on June 24, 2011.
Documents
Issuer
KV PHARMACEUTICAL CO /DE/
CIK 0000057055
Entity typeother
Related Parties
1- filerCIK 0001320271
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 12:45 PM ET
- Size
- 6.5 KB